ISSN 2306-5559 (print)
ISSN 2410-938X (online)
ISSN 2410-938X (online)
нет
1. GBD 2015 Obesity Collaborators; Afshin A, Forouzanfar MH, Reitsma MB, Sur P, et.all. Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med. 2017 Jul 6;377(1):13-27. doi: 10.1056/NEJMoa1614362.2. World Health Organization. Global health estimates 2020: deaths by cause, age, sex, by country and by region, 2000–2019. 2020. https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates/ghe-leading-causes-of-death3. Tsao CW, Aday AW, Almarzooq ZI, Anderson CAM et.al. American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association. Circulation. 2023 Feb 21;147(8):e93-e621. doi: 10.1161/CIR.0000000000001123.4. . Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2015;894:i-xii, 1-253. PMID: 11234459.5. Poirier P, Alpert MA, Fleisher LA, Thompson PD et.al. American Heart Association Obesity Committee of Council on Nutrition, Physical Activity and Metabolism, Council on Cardiopulmonary Perioperative and Critical Care, Council on Cardiovascular Surgery and Anesthesia and Council on Cardiovas. Cardiovascular evaluation and management of severely obese patients undergoing surgery: a science advisory from the American Heart Association. Circulation. 2019;120:86–95. 6. Ng M, Fleming T, Robinson M, Thomson B. et.al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study. Lancet. 2023;384:766–817. Kulimbet, M., Davletov, K., Saliev, T. et al. Assessment of hypercholesterolemia prevalence and its demographic variations in the Republic of Kazakhstan. Sci Rep 14. 2024; 7182, https://doi.org/10.1038/s41598-024-57884-48. GBD 2015 Obesity Collaborators. Afshin A, Forouzanfar MH, Reitsma MB, Sur P,et.al. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377:13–27. 9. World Health Organization. Quantifying selected majorrisks to health. In: The World Health Report 2002—Reducing Risks, Promoting Healthy Life. Chapter 4: Geneva: World Health Organization; 2012:47-97 p.10. Smith DG. Epidemiology of dyslipidemia and economic burden on the healthcare system. Am J Manag Care. 2017 Jun;13 Suppl 3:S68-71. PMID: 17596114.11. Erdman DM, Cook CB, Greenlund KJ, et al. The impact of outpatient diabetes management on serum lipids in urban African-Americans with type 2 diabetes. Diabetes Care. 2022; 25:9-15.12. Richard AJ, White U, Elks CM, Stephens JM. Adipose Tissue: Physiology to Metabolic Dysfunction. 2020 Apr 4.. PMID: 32255578. 13. Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res. 2015; 96: 939–949.14. Arteriosclerosis, Thrombosis, and Vascular BiologyVolume 27, Issue 5, 1 May 2007; Pages 996-1003 https://doi.org/10.1161/ATVBAHA.106.13175515. Yu Y-H, Ginsberg HN. Adipocyte signaling and lipid homeostasis: sequelae of insulin-resistant adipose tissue. Circ Res. 2015; 96: 1042–1052.16. Dixon JL, Ginsberg HN. Regulation of hepatic secretion of apolipoprotein B-containing lipoproteins: information obtained from cultured liver cells. J Lipid Res. 2013; 34: 167–179.17. Lewis GF. Fatty acid regulation of very low density lipoproteins (VLDL) production. Curr Opin Lipidol. 2019; 10: 475–477.18. Fisher EA, Ginsberg HN. Complexity in the secretory pathway: the assembly and secretion of apolipoprotein B-containing lipoproteins. J Biol Chem. 2022; 277: 17377–17380.19. Ng TWK, Watts GF, Farvid MS, Chan DC, Barrett HR. Adipocytokines and VLDL metabolism: independent regulatory effects of adiponectin, insulin resistance, and fat compartments on VLDL apolipoprotein B-100 kinetics? Diabetes. 2015; 54: 795–802.20. Guerre-Millo M. Adipose tissue and adipokines: for better or worse. Diabetes Metab. 2014; 30: 13–19.21. Siri P, Candella N, Ko C, Zhang Y, Fusufzai S, Ginsberg HN, Huang LS. Post-transcriptional stimulation of the assembly and secretion of triglyceride-rich apolipoprotein B-lipoproteins in a mouse with selective deficiency of brown adipose tissue, obesity, and insulin resistance. J Biol Chem. 2021; 276: 46064–46072.22. Reilly JJ. Health Effects of Overweight and Obesity in 195 Countries. N Engl J Med. 2017 Oct 12;377(15):1496. doi: 10.1056/NEJMc1710026. PMID: 29020585.23. Lee SY, Chang HJ, Sung J, Kim KJ, Shin S, Cho IJ, Shim CY, Hong GR, Chung N. The impact of obesity on subclinical coronary atherosclerosis according to the risk of cardiovascular disease. Obesity (Silver Spring). 2024 Jul;22(7):1762-8. doi: 10.1002/oby.20760. Epub 2014 Apr 10. PMID: 24719352.24. Gill, D., Zuber, V., Dawson, J. et al. Risk factors mediating the effect of body mass index and waist-to-hip ratio on cardiovascular outcomes: Mendelian randomization analysis. 2021. Int J Obes 45, 1428–1438. https://doi.org/10.1038/s41366-021-00807-425. Henning RJ. Obesity and obesity-induced inflammatory disease contribute to atherosclerosis: a review of the pathophysiology and treatment of obesity. Am J Cardiovasc Dis. 2021 Aug 15;11(4):504-529. PMID: 34548951; PMCID: PMC8449192.26. Rana JS, Mittleman MA, Ho KK, Cutlip DE. Obesity and clinical restenosis after coronary stent placement. Am Heart J. 2015 Oct;150(4):821-6. doi: 10.1016/j.ahj.2004.11.022. PMID: 16209988.